Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Blastic Plasmacytoid Dendritic Cell Neoplasm
Joseph D. Khoury
Current Hematologic Malignancy Reports (2018) Vol. 13, Iss. 6, pp. 477-483
Closed Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies
Branko Cuglievan, Jeremy Connors, Jiasen He, et al.
Leukemia (2023) Vol. 37, Iss. 9, pp. 1767-1778
Open Access | Times Cited: 23
Immunohistochemistry Innovations for Diagnosis and Tissue-Based Biomarker Detection
Narittee Sukswai, Joseph D. Khoury
Current Hematologic Malignancy Reports (2019) Vol. 14, Iss. 5, pp. 368-375
Closed Access | Times Cited: 71
DNA methyltransferase inhibition overcomes diphthamide pathway deficiencies underlying CD123-targeted treatment resistance
Katsuhiro Togami, Timothy J. Pastika, Jason Stephansky, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 11, pp. 5005-5019
Open Access | Times Cited: 70
Dual Expression of TCF4 and CD123 Is Highly Sensitive and Specific For Blastic Plasmacytoid Dendritic Cell Neoplasm
Narittee Sukswai, Phyu P. Aung, C. Cameron Yin, et al.
The American Journal of Surgical Pathology (2019) Vol. 43, Iss. 10, pp. 1429-1437
Closed Access | Times Cited: 68
Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm
Wei Wang, Joseph D. Khoury, Roberto N. Miranda, et al.
Haematologica (2020) Vol. 106, Iss. 4, pp. 1047-1055
Open Access | Times Cited: 54
CD123 as a Biomarker in Hematolymphoid Malignancies: Principles of Detection and Targeted Therapies
Hanadi El Achi, Édouard Dupont, Shilpa Paul, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3087-3087
Open Access | Times Cited: 38
Divergent clonal evolution of blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia from a shared TET2-mutated origin
Kiran Batta, Hasse M Bossenbroek, Naveen Pemmaraju, et al.
Leukemia (2021) Vol. 35, Iss. 11, pp. 3299-3303
Open Access | Times Cited: 29
Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy
Nathaniel R. Wilson, Marina Konopleva, Joseph D. Khoury, et al.
Clinical Lymphoma Myeloma & Leukemia (2021) Vol. 21, Iss. 11, pp. 734-740
Closed Access | Times Cited: 29
Integrated Clinical Genotype-Phenotype Characteristics of Blastic Plasmacytoid Dendritic Cell Neoplasm
C. Cameron Yin, Naveen Pemmaraju, M. James You, et al.
Cancers (2021) Vol. 13, Iss. 23, pp. 5888-5888
Open Access | Times Cited: 29
Response to Venetoclax in patients with Blastic Plasmacytoid Dendritic Cell Neoplasm
Kirsty Sharplin, Catherine Vassiliou, James Nguyen, et al.
Leukemia Research (2025) Vol. 152, pp. 107678-107678
Closed Access
Neoplasia blástica de células dendríticas plasmocitoide: un reto diagnostico
Katty Camila Anaya Reyes, Angelica Patricia Araujo Reyes, Jorge Andrés García-Vera
Revista de la Asociación Colombiana de Dermatología y Cirugía Dermatológica (2025) Vol. 33, Iss. 2
Open Access
Blastic Plasmacytoid Dendritic Cell Neoplasm: Progress in Cell Origin, Molecular Biology, Diagnostic Criteria and Therapeutic Approaches
Wei Cheng, Tiantian Yu, Aiping Tang, et al.
Current Medical Science (2021) Vol. 41, Iss. 3, pp. 405-419
Open Access | Times Cited: 18
Immunopathology of Kikuchi–Fujimoto disease: A reappraisal using novel immunohistochemistry markers
Narittee Sukswai, Hye Ra Jung, Samir S. Amr, et al.
Histopathology (2019) Vol. 77, Iss. 2, pp. 262-274
Closed Access | Times Cited: 19
PD1/PD-L1 Expression in Blastic Plasmacytoid Dendritic Cell Neoplasm
Phyu P. Aung, Narittee Sukswai, Reza Nejati, et al.
Cancers (2019) Vol. 11, Iss. 5, pp. 695-695
Open Access | Times Cited: 16
Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm
Andrew A. Lane
Hematology/Oncology Clinics of North America (2020) Vol. 34, Iss. 3, pp. 589-600
Closed Access | Times Cited: 15
Role of tagraxofusp in treating blastic plasmacytoid dendritic cell neoplasm (BPDCN)
Mansour Alfayez, Marina Konopleva, Naveen Pemmaraju
Expert Opinion on Biological Therapy (2019) Vol. 20, Iss. 2, pp. 115-123
Closed Access | Times Cited: 15
IRF8 may be a useful marker for blastic plasmacytoid dendritic cell neoplasm, especially with weak CD123 expression
Haiming Tang, Gauri Panse, Demetrios T. Braddock, et al.
Journal of Cutaneous Pathology (2023) Vol. 50, Iss. 7, pp. 595-600
Open Access | Times Cited: 4
Blastic plasmacytoid dendritic cell neoplasm: Two case reports
Yi-Qian Ma, Zhan Sun, Yumei Li, et al.
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 9, pp. 1207-1214
Open Access | Times Cited: 1
Blastic plasmacytoid dendritic cell neoplasm in the background of myeloproliferative disorder and chronic lymphocytic leukaemia
Abdul Moiz Khan, Ayesha Munir, Mihir Raval, et al.
BMJ Case Reports (2019) Vol. 12, Iss. 7, pp. e230332-e230332
Open Access | Times Cited: 11
Dendritic Cell Leukemia: a Review
Nikolaos J. Tsagarakis, Georgios Paterakis
Current Oncology Reports (2020) Vol. 22, Iss. 6
Closed Access | Times Cited: 11
Blastic Plasmacytoid Dendritic Cell Neoplasm Developed in Chronic Myeloid Leukemia in Molecular Remission During a Four-Year Treatment-Free Interval After Six Years of Dasatinib Treatment
Hiroshi Suzuki, Masataka Takeshita, Risen Hirai, et al.
Cureus (2024)
Open Access | Times Cited: 1
Blastic Plasmocytoid Dendritic Cell Neoplasm (BPDCN): Clinical Features and Histopathology with a Therapeutic Overview
Gerardo Cazzato, Marialessandra Capuzzolo, Emilio Bellitti, et al.
Hematology Reports (2023) Vol. 15, Iss. 4, pp. 696-706
Open Access | Times Cited: 3
Multiple Genomic Alterations, Including a Novel AFF4::IRF1 Fusion Gene, in a Treatment-Refractory Blastic Plasmacytoid Dendritic-Cell Neoplasm: A Case Report and Literature Review
Yavuz Şahin, Y. Lynn Wang, Jianming Pei, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 305-305
Open Access | Times Cited: 3
Myeloid diseases in the lung and pleura
Joseph D. Khoury, Weina Chen
Seminars in Diagnostic Pathology (2020) Vol. 37, Iss. 6, pp. 296-302
Closed Access | Times Cited: 6
Dendritic Cell Subpopulations Are Associated with Prognostic Characteristics of Breast Cancer after Neoadjuvant Chemotherapy—An Observational Study
Agnieszka Łazarczyk, Joanna Streb, Anna Glajcar, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15817-15817
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top